J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

A new investment in state-of-the-art technology aims to deliver faster diagnosis and treatment of cardiology patients. The ...

Her kindness, humor and thoughtfulness were very much appreciated by our family.” Waller has worked for Decatur Memorial Hospital since 2008 and was the DMH May Colleague of the Month in 2024. The ...

French Hospital Medical Center (FHMC) held a ribbon-cutting ceremony Friday afternoon to celebrate the opening of the new ...

Comprehensive Health will name the catheterization labs and boardroom of the future RM Schulze Family Heart and Stroke Critical Care Center after a recent $10 million gift from Jay and Patty Baker. ...

A fired White Howard University Hospital cardiac catheterization lab manager isn’t entitled to a trial on his Title VII race discrimination claims, because he offered no evidence for a reasonable jury ...

Despite projections of rapid growth, the outpatient migration of cardiology has not accelerated as expected — even as cardiology stands out as the fastest-growing ASC specialty, according to a 2022 ...

New research suggests cerebral embolic protection devices do not lower the risk of stroke in patients undergoing ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective ...

Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and pulmonary hypertension were found.

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...